Decoding Beta‐Lactam Cross‐Reactivity – Longitudinal Patch Testing From 2000 to 2022
Contact Dermatitis · 2025
DOI: 10.1111/cod.14767 ↗Kurz gefasst
Fachartikel in der Zeitschrift Contact Dermatitis, 2025. Verfasst von João Nuno Barbosa Soares und 5 weiteren Autor:innen. Beteiligte Einrichtung: Dermatology, University Hospital, Coimbra Local Health Unit, Coimbra, Portugal. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, beta-Lactams, Drug Eruptions. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 16 Literaturangaben.
Abstract (Originalsprache)
Introduction
Patients with non‐immediate hypersensitivity to beta‐lactam antibiotics (βL) often avoid all βL, with limitations for future therapy.
Objectives
Assess cross‐reactivity between βL in non‐immediate cutaneous adverse drug reactions (ni‐CADRs).
Methods
Retrospective analysis (2000–2022) of patients with suspected ni‐CADR with βL as a possible culprit who underwent patch testing (PT) with an extended antibiotic series (10% pet., Chemotechnique Diagnostics or prepared in‐house) according to European Society of Contact Dermatitis (ESCD) recommendations. Fisher exact test was used with a significance of 0.05 corrected for multiple testing; positive associations were quantified with odds ratio (OR) with 95% confidence interval (CI).
Results
Four hundred and fourteen patients (270 female/144 male; age 52 ± 19 years) were included, mostly with maculopapular exanthema (367; 89%), drug reaction with eosinophilia and systemic symptoms (DRESS) (22; 5%) and acute generalised exanthematous pustulosis (AGEP) (12; 3%). Eighty‐six patients (21%) had positive results to at least one drug. Fifty‐eight patients (14%) had 110 positive results to βL, mostly amoxicillin (33). Co‐reactivity within penicillins was almost universal, including piperacillin with other penicillins ( p = 0.007; OR 25; CI 3–56). There was co‐reactivity to aminopenicillins and aminocephalosporins ( p = 0.006; OR 33; CI 4–74) and within the cephalosporin subclass, including between aminocephalosporins and non‐aminocephalosporins. Within carbapenems, 1 patient reacted to meropenem and ertapenem, with no extension to imipenem, as confirmed with a provocation test. Two patients reacted both to ceftriaxone and meropenem ( p = 0.013; OR: 68; CI:15–612).
Conclusion
PT is useful to confirm a probable culprit in ni‐CADR to βL. Co‐reactivity, interpreted mostly as cross‐reactivity, occurred within cephalosporin and, particularly, with penicillin subclasses, including between piperacillin‐tazobactam and remaining penicillins, which has seldom been described. There was no association between penicillins and cephalosporins as a whole, except between aminopenicillins and aminocephalosporins, attributable to a similar lateral chain amino group. We found an unexpected association between meropenem and ceftriaxone, probably a concomitant sensitization.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Dermatology, University Hospital, Coimbra Local Health Unit, Coimbra, Portugal.
- Faculty of Medicine, University of Coimbra, Coimbra, Portugal.
ORCID-Profile: João Nuno Barbosa Soares, Margarida Gonçalo
Zitieren
APA
Soares, J. N. B., Martins, A. A., Figueiredo, A. C., Pinho, A. C., Caramelo, F., & Gonçalo, M. (2025). Decoding Beta‐Lactam Cross‐Reactivity – Longitudinal Patch Testing From 2000 to 2022. Contact Dermatitis. https://doi.org/10.1111/cod.14767
Vancouver
Soares JNB, Martins AA, Figueiredo AC, Pinho AC, Caramelo F, Gonçalo M. Decoding Beta‐Lactam Cross‐Reactivity – Longitudinal Patch Testing From 2000 to 2022. Contact Dermatitis. 2025. doi:10.1111/cod.14767
BibTeX
@article{Soares2025,
author = {Soares, João Nuno Barbosa and Martins, André Aparício and Figueiredo, Ana Carolina and Pinho, André Castro and Caramelo, Francisco and Gonçalo, Margarida},
title = {Decoding Beta‐Lactam Cross‐Reactivity – Longitudinal Patch Testing From 2000 to 2022},
journal = {Contact Dermatitis},
year = {2025},
doi = {10.1111/cod.14767}
}
EUVIMED